These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9299866

  • 1. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.
    Zaja F, Fanin R, Silvestri F, Russo D, Infanti L, Baccarani M.
    Haematologica; 1997; 82(4):468-70. PubMed ID: 9299866
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.
    Zinzani PL, Tani M, Marchi E, Stefoni V, Alinari L, Musuraca G, Gabriele A, Pileri S, Baccarani M.
    Haematologica; 2004 Mar; 89(3):309-13. PubMed ID: 15020269
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
    Jehn U, Bartl R, Dietzfelbinger H, Haferlach T, Heinemann V.
    Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
    [Abstract] [Full Text] [Related]

  • 10. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G, Schirmer M, Hilbe W, Fend F, Geisen F, Knoblechner A, Petzer A, Thaler J.
    Blood Cells Mol Dis; 1995 Sep; 21(2):142-51. PubMed ID: 8846043
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of hairy cell leukemia with cladribine].
    Aurer I, Mitrović Z, Kovacević-Metelko J, Radman I, Basić-Kinda S, Gjadrov-Kuvezdić K, Jakić-Razumović J, Dubravcić K, Ries S, Nola M, Zupancic-Salek S, Labar B.
    Lijec Vjesn; 2007 Sep; 129(3-4):80-3. PubMed ID: 17557550
    [Abstract] [Full Text] [Related]

  • 13. [Successful ambulatory treatment of patients with hairy-cell leukemia using one cycle of the purine analog cladribine. 'Hemato-oncologic volwassen Nederland' (HOVON) Study Group].
    Raemaekers JM, van 't Veer MB, Bogman MJ.
    Ned Tijdschr Geneeskd; 1996 Aug 03; 140(31):1600-4. PubMed ID: 8768814
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L, Domingo JM, Sola C, Azaceta G, Calvo MT, Gutierrez M.
    Haematologica; 2002 Jan 03; 87(1):107-8. PubMed ID: 11801472
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia.
    Benz R, Siciliano RD, Stussi G, Fehr J.
    Eur J Haematol; 2009 Mar 03; 82(3):194-200. PubMed ID: 19077050
    [Abstract] [Full Text] [Related]

  • 19. [Intermittent interferon alfa in the treatment of hairy cell leukemia].
    Gómez-Almaguer D, Jaime-Pérez JC, Herrera-Garza JL, González-Llano O.
    Rev Invest Clin; 1998 Mar 03; 50(4):331-4. PubMed ID: 9830322
    [Abstract] [Full Text] [Related]

  • 20. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
    Tallman MS, Hakimian D, Kopecky KJ, Wheaton S, Wollins E, Foucar K, Cassileth PA, Habermann T, Grever M, Rowe JM, Peterson LC.
    Clin Cancer Res; 1999 Jul 03; 5(7):1665-70. PubMed ID: 10430066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.